Explore our primary inventory of advanced peptides, regulatory APIs, and specialty chemical building blocks engineered under strict cGMP compliance.
China’s specialty chemical manufacturing sector has evolved from high-volume commodity synthesis into a world-class hub for bio-pharmaceutical APIs, custom peptide chains, and high-purity research compounds.
The global pharmaceutical R&D ecosystem relies heavily on specialized chemical intermediates and therapeutic peptide APIs to accelerate drug discovery pipelines. Historically, global supply chains suffered from fragmented manufacturing standards, inconsistent lot-to-lot purity, and regulatory friction. Over the past decade, premier Chinese research chemical manufacturers—such as Gentolex Group—have bridged this gap by integrating state-of-the-art Solid-Phase Peptide Synthesis (SPPS) automated lines, continuous flow chemical reactors, and rigorous international quality control standards (cGMP, FDA DMF, and ISO 9001/14001 certification).
This structural evolution ensures that academic institutions, biotechnology enterprises, and clinical development firms gain access to pure active compounds—ranging from complex antisense oligonucleotide intermediates like Donidalorsen to targeted peptide sequences such as BPC-157, Semax, and Elamipretide (SS-31). Modern chemical synthesis protocols mandate complete transparency in impurity profiling, heavy metal detection via ICP-MS, and structural confirmation utilizing high-field 1H/13C NMR and LC-MS spectrometry.
Systematic breakdown of scientific workflows, purification technologies, and analytical validation methodologies employed in research chemical manufacturing.
Utilizing microwave-assisted Solid-Phase Peptide Synthesis (SPPS) alongside scale-up Liquid-Phase Peptide Synthesis (LPPS). This hybrid approach guarantees high sequence fidelity, minimal epimerization, and high yield for long-chain synthetic peptides and modified amino acids.
Expertise in complex protecting group strategies, including Fmoc-Lys(Pal-Glu-OtBu)-OH and Ste-γ-Glu-AEEA-AEEA-OSU. Precision chemistry enables exact disulfide bond formation and lipophilic fatty acid conjugation for long-acting peptide formulations.
Industrial prep-HPLC networks operating with reverse-phase C18 and C8 columns. Multi-stage gradient purification yields target product fractions above 99.0% purity while systematically clearing truncated deletion sequences and trifluoroacetate (TFA) salts.
| Product Category | Key Target Standards | Primary Analytical Testing Methods | Regulatory File Support |
|---|---|---|---|
| Peptide Active Ingredients (APIs) | Purity ≥ 98.0% - 99.5%, Single Impurity < 0.5% | RP-HPLC, ESI-MS, High-Field 1H-NMR, TFA Counterion Quantification | DMF, ASMF, cGMP COA, Batch Release Records |
| Custom Peptide Intermediates | Sequence Identity 100%, Endotoxin < 10 EU/mg | Mass Spectrum Verification, Residual Solvent Headspace GC-MS | ISO 9001 Qualification, R&D Certificate |
| Specialty Eco-Plasticizers | Color (APHA) ≤ 30, Acid Value < 0.1 mg KOH/g | Gas Chromatography (GC), Moisture Karl Fischer Titration | REACH Registration, RoHS Compliance Report |
| Hormone Regulators | Chiral Purity ≥ 99.8%, Bio-assay Activity Validated | Chiral HPLC, UV-Vis Spectrophotometry, Microbial Limit Test | cGMP Protocol, Stability Data under ICH Guidelines |
Addressing supply chain risk mitigation, licensing models, and global logistics for international pharmaceutical and research institutions.
Global pharmaceutical entities often face complex procurement bottlenecks when sourcing multiple raw materials across disparate international suppliers. Managing multiple contracts, audit processes, freight channels, and customs clearances adds severe operational overhead.
Integrated supply chain solutions resolve these challenges by offering single-point procurement services. By leveraging standard facilities spanning over 250,000 square meters, research clients receive unified quality assurances, streamlined documentation (cGMP/ISO), and predictable lead times.
Furthermore, local operational hubs established in strategic regions—including Mexico and South Africa—provide regional client support, emergency buffer stock, and simplified import customs handling.
Connecting global biopharma with superior engineering, reliable product streams, and standard manufacturing assets.
Gentolex’s overarching goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specifically establishing active representative centers in Mexico and South Africa.
Our core services encompass supplying peptide APIs, custom synthesized peptides, FDF license-out solutions, technical support & consultation, product line and laboratory setup, as well as comprehensive sourcing and supply chain solutions.
With an overall factory construction area of 250,000 square meters built strictly under international standards, we offer flexible, highly scalable, and cost-effective solutions for early-stage R&D up to commercial batch manufacturing.
Latest scientific publications, technical disclosures, and research API product deep-dives from our R&D engineering teams.
Introduction to Selank Acetate API: A synthetic heptapeptide active pharmaceutical ingredient composed of the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). Originally developed for neuropharmacological R&D...
View Details
Trusted Thymosin Beta-4 API manufacturer and supplier, providing high-purity Tβ4 peptide solutions for biotechnology companies, pharmaceutical research organizations, and cellular repair studies...
View Details
BPC-157 API is a synthetic pentadecapeptide that has gained increasing attention in peptide research due to its potential biological activities related to tissue repair and gastrointestinal protection...
View Details
With continuous developments in neuroscience and peptide technology, neuroactive peptides have become a key research focus. Semax, derived from an ACTH fragment, features unique molecular structures...
View Details
SS-31 API (Elamipretide, MTP-131) is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner mitochondrial membrane, supporting cellular bioenergetics...
View DetailsExpert insights addressing user intent, quality control validation, compliance documents, and international logistics.
Complete directory of specialized building blocks, eco-plasticizers, and regulatory active compounds.
